Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies

NACompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

May 31, 2016

Conditions
Reproductive Sterility
Interventions
DRUG

Prednisolone treatment

Infertile men were treated with prednisolone tablet, which is an intermediate acting corticosteroid, po, for 21 days of their wife's menstrual cycles. Briefly, the prednisolone regimen was started with a dose of 5mg, tid, for two weeks followed by 5mg bid for five days. This was further tapered to one tablet of 5mg/day for two days. Patients were then given one week of rest from the treatment, before this prednisolone regimen was repeated for another two cycles.

All Listed Sponsors
collaborator

University of Baghdad

OTHER

lead

Barz IVF Center for Infertility Treatment and Embryo Research

OTHER

NCT02935738 - Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies | Biotech Hunter | Biotech Hunter